| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Nature's Sunshine Products, Inc
13D/A
Amendment 3
NATR · 639027101
|
0.4% |
6/27/2025
Event 6/25/2025
|
|||
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 0.4% | ||||
| Fosun Pharma USA Inc. | 0% | ||||
|
Nature's Sunshine Products, Inc
13D/A
Amendment 2
NATR · 639027101
|
15.9% |
6/9/2025
Event 6/5/2025
|
|||
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 15.9% | ||||
| Fosun Pharma USA Inc. | 15.6% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.